These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2659954)

  • 21. Tibolone: the way to beat many a postmenopausal ailments.
    Lazovic G; Radivojevic U; Marinkovic J
    Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.
    Lindsay R; Hart DM; Kraszewski A
    Br Med J; 1980 May; 280(6225):1207-9. PubMed ID: 6992927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
    Landgren MB; Helmond FA; Engelen S
    Maturitas; 2005 Mar; 50(3):222-30. PubMed ID: 15734603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term effects of guar gum on metabolic control, serum cholesterol and blood pressure levels in type 2 (non-insulin-dependent) diabetic patients with high blood pressure.
    Uusitupa M; Tuomilehto J; Karttunen P; Wolf E
    Ann Clin Res; 1984; 16 Suppl 43():126-31. PubMed ID: 6398982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients.
    Nevinny-Stickel J
    Arch Gynecol; 1983; 234(1):27-31. PubMed ID: 6660926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML; Evans GW; Riley W; McBride KH; Paskett ED; Helmond FA; Grobbee DE;
    Eur Heart J; 2006 Mar; 27(6):746-55. PubMed ID: 16415304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14.
    Cortes-Prieto J
    Maturitas; 1987; Suppl 1():67-72. PubMed ID: 3306292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
    Laan E; van Lunsen RH; Everaerd W
    Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-linear increase in vertebral density induced by a synthetic steroid (Org OD 14) in women with established osteoporosis.
    Geusens P; Dequeker J; Gielen J; Schot LP
    Maturitas; 1991 Jun; 13(2):155-62. PubMed ID: 1921738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teriparatide (biosynthetic human parathyroid hormone 1-34): a new paradigm in the treatment of osteoporosis.
    Brixen KT; Christensen PM; Ejersted C; Langdahl BL
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):260-70. PubMed ID: 15228497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of Org OD 14--a new steroidal therapy for climacteric symptoms.
    Hardiman P; Nihoyannopoulos P; Kicovic P; Ginsburg J
    Maturitas; 1991 Sep; 13(3):235-42. PubMed ID: 1943831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tibolone: a steroid with a tissue-specific mode of action.
    Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2001; 76(1-5):231-8. PubMed ID: 11384882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of Org OD 14 in the treatment of climacteric complaints.
    Trévoux R; Dieulangard P; Blum A
    Maturitas; 1983 Aug; 5(2):89-96. PubMed ID: 6633272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tibolone. KB 889, ORG OD 14, ORG OD14, Livial, Livifem, Boltin.
    Drugs R D; 1999 Mar; 1(3):225-7. PubMed ID: 10566032
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term effects of Org OD 14 on lipid metabolism in post-menopausal women.
    Kloosterboer HJ; Benedek-Jaszmann LJ; Kicovic PM
    Maturitas; 1990 Apr; 12(1):37-42. PubMed ID: 2333035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of Org OD 14 and 17 beta-oestradiol on bone and lipid metabolism in early post-menopausal women.
    Netelenbos JC; Siregar-Emck MT; Schot LP; van Ginkel FC; Lips P; Leeuwenkamp OR
    Maturitas; 1991 Jun; 13(2):137-49. PubMed ID: 1921737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters.
    Paterson ME
    Maturitas; 1982 Aug; 4(2):83-94. PubMed ID: 6750325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein A1 levels in oophorectomized women treated with Org OD 14, oestradiol valerate and a placebo.
    Crona N; Silfverstolpe G; Enk L; Samsioe G
    Maturitas; 1984 Dec; 6(4):335-9. PubMed ID: 6442754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trial of synthetic steroid for preventing postmenopausal osteoporosis.
    Coope J
    Br Med J; 1980 Aug; 281(6237):456-7. PubMed ID: 7427322
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.